Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease

Pulmonary hypertension (PH) with developmental lung disease is a life-threatening disease and accounts for 10%–12% of pediatric PH patients. Administration of specific pulmonary vasodilators to pediatric PH patients has brought about improvement of their long-term prognosis. Intravenous epoprostenol...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukasawa, Yoshie, Yamamoto, Hidenori, Ito, Miharu, Saito, Akiko, Go, Kiyotaka, Morimoto, Yoshihito, Yasuda, Kazushi, Sato, Yoshiaki, Hayakawa, Masahiro, Kato, Taichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020523/
https://www.ncbi.nlm.nih.gov/pubmed/36937960
http://dx.doi.org/10.3389/fped.2023.1116434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020523/
https://www.ncbi.nlm.nih.gov/pubmed/36937960
http://dx.doi.org/10.3389/fped.2023.1116434

Ejemplares similares